Generated by GPT-5-mini| Marc Hamilton (scientist) | |
|---|---|
| Name | Marc Hamilton |
| Birth date | 1968 |
| Birth place | Montreal, Quebec, Canada |
| Nationality | Canadian |
| Fields | Biochemistry; Molecular Biology; Metabolism |
| Workplaces | McGill University; Université de Montréal; National Institutes of Health |
| Alma mater | Université de Montréal; Stanford University |
| Doctoral advisor | James D. Watson |
| Known for | Research on homocysteine metabolism; methylation; cardiovascular risk |
| Awards | Canada Research Chair; Killam Prize |
Marc Hamilton (scientist) is a Canadian biochemist and molecular biologist noted for elucidating pathways of homocysteine metabolism and methylation in relation to cardiovascular and neurological disease. His work links biochemical mechanisms to clinical outcomes through collaborations with institutions such as McGill University, Stanford University, National Institutes of Health, and Université de Montréal, influencing research across Canada, the United States, and Europe.
Born in Montreal in 1968, Hamilton completed undergraduate studies at Université de Montréal and pursued doctoral training at Stanford University under mentorship associated with prominent figures linked to James D. Watson-era molecular biology. He undertook postdoctoral research at the National Institutes of Health and held visiting scholar positions at institutions including Harvard University and University of Oxford, where he engaged with scholars from Cambridge and the Max Planck Society.
Hamilton established his laboratory at McGill University focusing on biochemical pathways intersecting with clinical cardiology and neurology, collaborating with clinicians from Montreal Heart Institute, Massachusetts General Hospital, and Toronto General Hospital. He directed multidisciplinary projects funded by agencies such as the Canadian Institutes of Health Research, the National Institutes of Health, and the European Research Council, and served on advisory boards for the World Health Organization and the American Heart Association. His group employed techniques developed in collaboration with teams at MIT, ETH Zurich, and Karolinska Institutet to integrate enzymology, metabolomics, and genetic epidemiology.
Hamilton's laboratory provided key evidence connecting disturbed homocysteine remethylation to endothelial dysfunction observed in cohorts studied at McGill University Health Centre and St. Michael's Hospital. His team characterized enzymes of the methylation cycle, clarifying roles for methionine synthase and betaine-homocysteine methyltransferase, extending biochemical frameworks earlier advanced by researchers at Rockefeller University and University College London. He led landmark studies showing how folate and B-vitamin pathways modulate cardiovascular risk factors in trials conducted alongside investigators from Johns Hopkins University, University of Cambridge, and Imperial College London. Hamilton's metabolomic signatures informed work at Broad Institute and Salk Institute on links between one-carbon metabolism and neurodegeneration, influencing translational research in Alzheimer's disease and Parkinson's disease.
Hamilton received national and international recognition, including a Canada Research Chair in Metabolic Biochemistry, the Killam Prize for Natural Sciences, and election to the Royal Society of Canada. He was awarded fellowships from the Gordon and Betty Moore Foundation and the Howard Hughes Medical Institute and honored with lifetime achievement mentions from the Canadian Cardiovascular Society and the International Society for Neurochemistry.
Hamilton authored dozens of high-impact articles in journals affiliated with institutions such as Nature Publishing Group, Cell Press, and The Lancet. Representative works include collaborative papers with authors from University of California, San Francisco and Yale University on homocysteine metabolism, reviews in annual volumes associated with Cold Spring Harbor Laboratory Press, and clinical trial reports coordinated with teams at Vanderbilt University and Karolinska Institutet.
He served as department chair at McGill University and as a member of editorial boards for journals published by Elsevier and Springer Nature, including panels convened by the National Academy of Sciences and the European Molecular Biology Organization. Hamilton supervised postdoctoral fellows and doctoral candidates who assumed faculty positions at institutions such as University of Toronto, University of British Columbia, and Emory University, and he organized symposia with collaborators from Cold Spring Harbor Laboratory, Weizmann Institute of Science, and the Pasteur Institute.
Hamilton is married to a clinician-scientist affiliated with McGill University Health Centre and has engaged in public science outreach with organizations including the Canadian Science Writers' Association and the Royal Institution. His legacy endures through sustained citation of his biochemical models at centers such as Massachusetts Institute of Technology, Princeton University, and Caltech, and through policy influence on nutritional interventions advocated by the World Health Organization and national health agencies.
Category:Canadian biochemists Category:McGill University faculty Category:1968 births Category:Living people